Pliant Therapeutics
Steve Ho is a Senior Scientist with experience in translational biology and tissue engineering. Steve has a PhD in Biomedical Engineering from UC Davis and has conducted research in various areas including biomaterials, stem cells, and skeletal muscle metabolism. Steve has also worked as a lab technician and undergraduate researcher at the University of Michigan. Steve is currently involved in leading programs related to anti-fibrotic compound efficacy and single nuclei RNA sequencing at Pliant Therapeutics.
Pliant Therapeutics
Pliant is advancing drug development programs targeting a range of fibrotic diseases, with a focus on fibrotic tissue-specific inhibition of integrins and the TGF-β pathway.